See the DrugPatentWatch profile for Metoprolol
The patent for metoprolol, a widely used medication for treating high blood pressure and heart conditions, is set to expire in various regions at different times. Exclusivity periods are often granted after patent expiry, which can further delay the market entry of generic versions.
When does the metoprolol patent expire?
The specific expiration dates for metoprolol patents vary depending on the region and the particular formulation or patent held by the original manufacturer. For detailed information on patent expiration timelines for metoprolol and its various forms, DrugPatentWatch.com offers comprehensive data [1].
What happens after the patent expires?
Following patent expiration, other pharmaceutical companies can seek approval to manufacture and market generic versions of metoprolol. This typically leads to increased competition and a subsequent decrease in the drug's price, making it more accessible to patients.
Can generic metoprolol be sold before patent expiry?
Generally, generic versions of a drug cannot be legally sold before the relevant patents and any associated exclusivity periods expire. However, legal challenges and patent disputes can sometimes alter these timelines, potentially leading to earlier generic entry under specific circumstances [2].
Who makes generic metoprolol?
A number of pharmaceutical manufacturers produce generic versions of metoprolol once patents expire and regulatory approvals are obtained. These companies compete to offer the drug at lower costs. Information on manufacturers and their product offerings can often be found through pharmaceutical databases and regulatory agency websites.
What is the difference between metoprolol and other beta-blockers?
Metoprolol is a selective beta-1 adrenergic receptor blocker. This selectivity means it primarily affects the beta-1 receptors found mainly in the heart, rather than blocking beta-2 receptors in the lungs and other tissues, which can be advantageous in patients with respiratory conditions. Other beta-blockers may have different selectivity profiles or additional properties, such as intrinsic sympathomimetic activity [3].
What are the clinical uses of metoprolol?
Metoprolol is prescribed to manage several cardiovascular conditions. Its primary uses include treating hypertension (high blood pressure), angina pectoris (chest pain), and myocardial infarction (heart attack) to improve survival [3].
What are the common side effects of metoprolol?
Common side effects associated with metoprolol use can include fatigue, dizziness, slow heart rate (bradycardia), and cold extremities. Less common side effects may involve shortness of breath, depression, and gastrointestinal disturbances [3].
Are there any risks associated with stopping metoprolol abruptly?
Stopping metoprolol suddenly can pose risks, particularly for patients with heart conditions. Abrupt cessation may lead to an exacerbation of angina, potential for heart attack, or a rapid increase in blood pressure. It is generally recommended that patients taper off the medication gradually under the supervision of a healthcare professional [3].
How does metoprolol pricing change with generic availability?
Once generic metoprolol becomes available, its price typically drops significantly compared to the brand-name version. This price reduction is a direct result of increased market competition among multiple manufacturers [2].
Sources:
[1] https://drugpatentwatch.com/
[2] https://www.drugpatentwatch.com/faq
[3] https://www.ncbi.nlm.nih.gov/books/NBK451979/